Institutional & Family Asset Management, LLC Tekla Life Sciences Investors Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$15.54 - $17.47 $1,554 - $1,747	-100 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$15.5 - $17.9 $1,550 - $1,789	100 New	100 $2,000

Others Institutions Holding HQL

# of Institutions

Shares Held

9.65M

Call Options Held

Put Options Held

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$44.7 Million
1.11% of portfolio
Penserra Capital Management LLC Orinda, CA

828K
Shares

$10.8 Million
0.2% of portfolio
Karpus Management, Inc. Pittsford, NY

490K
Shares

$6.38 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.43 Million
0.12% of portfolio
Absolute Investment Advisers LLC

400K
Shares

$5.21 Million
0.67% of portfolio

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account